| Acquirer | Target | Price |
|---|---|---|
| Royalty Pharma | Rights to royalty stream of Tysabri® | $2.2 billion |
| CareTrust REIT, Inc. | Illinois skilled nursing portfolio | $29.2 million |
| Sartorius AG | Essen BioScience Inc. | $320 million |
| The Everett Clinics | Totem-Lake Family Medicine | N/A |

